Aurobindo Pharma’s stock, after a 100% rally in FY24, faced resistance but is now showing signs of bottoming out. Experts suggest a possible rise above Rs 1,300 for short-term traders.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
